Omitting bleomycin from the standard ABVD regimen following a negative PET scan resulted in lower incidence of pulmonary adverse events among patients with advanced Hodgkin lymphoma, according to study results published inThe New England Journal of Medicine. {read more here}

At this year’s SNMMI, researchers discussed using PET/CT imaging and Ga-68 PSMA, which is a combination of a radioactive material and molecular compound, to accurately detect tumors while guiding a surgeon during biopsy of a prostate cancer patient. {read more here}

The fourth and subsequent PET/CT scans performed after the completion of primary treatment led to a change in management in 27.7% of patients when the scans were performed with clinical suspicion and only in 6.7% of patients when performed without clinical suspicion or context.  {read more here}

FDG-PET is a considerably better predictor of treatment response and outcome than fluoride-PET for breast cancer patients with metastatic bone lesions, concluded researchers on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference. {read more here}